The latest international news, analysis and features on the HIV epidemic from AVERT. Share your views and expertise with your peers in the comments box below the articles.
Drug trial results for new integrase inhibitor show promising viral suppression rates.
Targeting the human genes that HIV takes over and uses to replicate could provide a new approach to HIV treatment and suppression – although more research is required.
One of the first studies into viral communication shows that viruses that infect bacteria (phages) leave chemical messages for each other which help them decide whether to kill or linger. Disrupting these messages could provide a new way to control HIV.
New HIV vaccine trial builds on success of 2009 Thai trial that showed 31.2% effectiveness in preventing HIV.
Over 300,000 AIDS-related deaths each year could be prevented through better diagnosis and treatment of fungal infections
Viral load testing could become more accessible to millions of people living with HIV in sub-Saharan Africa thanks to a new USB testing stick.
The natural ability of some children's immune systems to hold off attacking HIV, thus stopping diseases progression, may provide clues for future treatment.
A once-a-week injection that can offer ‘complete viral-load suppression’ for up to 17 months, could be available from 2017 according to Pharmaceutical company CytoDyn Inc. following a trial of 23 patients.